Zap to see: electrical therapy for eye disease
NCT ID NCT02086890
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a treatment called transcorneal electrical stimulation to see if it can improve vision in people with retinitis pigmentosa, an eye disease that causes vision loss. Twenty-one adults with the condition received the therapy, and researchers measured changes in their visual field and sharpness over about 4-6 months. The goal is to find a way to ease symptoms and slow vision decline.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nova Southeastern University; College of Optometry
Fort Lauderdale, Florida, 33328, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A sharper look at the retina: new imaging technology may spot eye disease earlier
- Stem cell eye transplant aims to halt blindness from rare genetic disease
- Could stem cells restore sight in damaged eyes?
- Gene therapy injection aims to restore sight in rare blindness
- Ground-Level vision test could help retinitis pigmentosa patients walk better
- New eye camera could unlock secrets of inherited blindness